echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > BMJ subjournal Anding Xu, Nan University: Correlation between HDL-C/LDL-C and myocardial infarction, all-cause death, and stroke

    BMJ subjournal Anding Xu, Nan University: Correlation between HDL-C/LDL-C and myocardial infarction, all-cause death, and stroke

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The objective of this study was to explore the correlation between HDL-Cholesterol (HDL-C)/LDL-C) and myocardial infarction (MI), all-cause mortality, hemorrhagic stroke and ischemic stroke, as well as the co-relationship between


    The study selected 384093 participants


    After comprehensive multivariate adjustment, HDL-C/LDL-C<0.


    In UKB participants, an HDL-C/LDL-C ratio of 0.


     

    References:

    Yuan S, Huang X, Ma W, Yang R, Xu F, Han D, Huang T, Peng M, Xu A, Lyu J.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.